Despite the decreased level of total NK cells observed in these patients compared to convalescents or infection-naïve individuals, the production of IFN-γ was not impaired in patients with moderate COVID-19 in a clinical setting (with no need for ICU admission). The gene discussed is IFNG; the disease is COVID-19.